Healthy Women Faced with Breast Removal Option Based on Gene Testing

Women, who carry the gene mutation BRCA, may be faced with the decision of having mastectomy to avoid developing breast cancer. According to Dutch researchers, presenting at the 6th European Breast Cancer Conference in Berlin, Germany, women who carry the BRCA gene mutation have an estimated 85% lifetime risk of developing breast cancer. Surgical breast removal, or mastectomy, reportedly reduces that risk to less than 1%. Previous studies have shown that the risk of cancer could be reduced by 3%. Read more

Increased MRI Use May Be Driving Increase in Mastectomies

After a seven-year dip in numbers, researchers at the Mayo Clinic in Rochester, Minnesota, have witnessed a steady increase in the number of mastectomies performed there in the past three years.  Evidence reveals a correlation between the higher number of mastectomies performed during the early stages of breast cancer and the use of diagnostic magnetic resonance imaging (MRI) prior to surgery. Read more

Actress Fights “Drive-through” Mastectomies

January 25, 2008 by MedHeadlines  
Filed under Breast Cancer, Women's Health

Desperate Housewife actress Marcia Cross met with lawmakers yesterday to express her support for a new law that would mandate minimal hospital stays for mastectomy patients. She is championing the Breast Cancer Protection Act of 2007 that would stop “drive-through” mastectomies. In addition to meeting with lawmakers, she is also filming public service announcements to raise awareness of the issue. Read more

Fat-rich Stem Cells Offer Hope For Breast Cancer Patients

December 19, 2007 by MedHeadlines  
Filed under Breast Cancer, Women's Health

fat cellsMed Headlines - There’s good news for the millions of women who have been left with breast defects after having cancerous lumps removed. A Japanese study released this week shows that stem cells from liposuctioned fat can be used to treat breast defects in women who have had cancerous lumps removed. The study was presented at the San Antonio Breast Cancer Symposium. The company that developed the treatment, Cytori Therapeutics, plans larger studies in Europe and Japan next year. Read more